- Details
The first clinical trial of an extended-release formulation of travoprost shows it’s comparable to topical once-daily travoprost in patients with glaucoma.
- Details
Alcon reports that the U.S. FDA has approved its AcrySof IQ aspheric IOL with the UltraSert pre-loaded delivery system.
- Details
A complete work-up immediately following nonarteritic central retinal artery occlusion picks up undiagnosed cardiovascular risk factors in almost 80% of patients.
Read more: CRAO patients at high risk for undiagnosed cardiovascular risk factors
- Details
Results from a phase 3 trial shows vision restoration in patients with RPE65-mediated inherited retinal dystrophies.
Read more: Gene therapy for retinal dystrophies meets endpoint
- Details
The 2-piece system allows for easy exchange of the optic to correct residual refractive error during surgery or 3 months postop.
- Details
InnFocus secured $32.8 million in Series C financing to fund the study of its MicroShunt glaucoma drainage system.